ORPHA:324625
Chikungunya
Publications
39,025
Trials
62
Interventional, condition-specific
Researchers
1,352
Distinct authors in sample
Gene link
—
Readiness
2/6
Stages with a signal
Clinical definition (Orphanet)
A rare infectious disease characterized by acute onset of high fever associated with debilitating polyarthralgia and usually accompanied by an erythematous skin rash (that may progress to vesiculobullous lesions in children) caused by the mosquitoe-borne Chikungunya virus. Myalgia, severe headache, and lymphadenopathy are frequently associated. Chronically the disease may cause recurrent, long-term polyarthralgia, arthritis, fatigue, and depression.
How rare: How common this is has not been clearly measured.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0017941
- MeSH:D065632
- UMLS:C0008055
- NCIT:C128422
Additional Mondo synonyms (4)
Chikungunya fever · Chikungunya virus caused disease or disorder · Chikungunya virus disease or disorder · Chikungunya virus infectious disease
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
2/6 stages with a signal
An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
39,025 matched papers (28,406 in last 10 years) Source
- Phenotype characterisedNot checked
Not yet enriched from Monarch / HPO
- Animal modelNot checked
Not yet enriched from Monarch / Alliance
- Orphan designationNot checked
FDA/EMA orphan-drug designation not enriched yet
- Interventional trialPresent
62 matched on ClinicalTrials.gov (12 recruiting in sample)
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
Not enriched in this build — Monarch phenotype joins were not run for this record.
Animal models (Monarch / Alliance)
Not enriched in this build.
Literature
Is anyone studying this?
39,025
39,025 papers — among the better-studied rare conditions, though still a fraction of common-disease literature (breast cancer: over 700,000). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=5449) is 41.
39,025 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 41 (publications denominator n=5449).
28,406 in the last 10 years · low confidence
Phrase hits: 39,025 · MeSH hits: 196
Who's working on it?
1,352
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.
- 01Li Y8 papers · 2026
Guangdong Provincial Center for Disease Control and Prevention, Guangzhou City, Guangdong Province, China.
Papers in Europe PMC - 02Liu J7 papers · 2026
Department of Epidemiology and Biostatistics, Peking University, Beijing, China.
Papers in Europe PMC - 03Liu Y7 papers · 2026
Department of Epidemiology and Biostatistics, Peking University, Beijing, China.
Papers in Europe PMC - 04Wang Y7 papers · 2026
Department of Epidemiology and Biostatistics, Peking University, Beijing, China.
Papers in Europe PMC - 05He J6 papers · 2026
Guangdong Provincial Center for Disease Control and Prevention, Guangzhou City, Guangdong Province, China.
Papers in Europe PMC - 06Huang J6 papers · 2026
First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, People's Republic of China.
Papers in Europe PMC - 07Huang X6 papers · 2026
Foshan Center for Disease Control and Prevention, Foshan City, Guangdong Province, China.
Papers in Europe PMC - 08Chen T5 papers · 2026
State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Innovation Platform for Industry-Education Integration in Vaccine Research, School of Public Health, Xiamen University, 4221-117 South Xiang'an Road, Xiang'an District, Xiamen City, Fujian Province, 361102, People's Republic of China. chentianmu@xmu.edu.cn.
Papers in Europe PMC - 09Chen X5 papers · 2026
Faculty of Life Science and Technology & Yunnan Provincial Key Laboratory of Public Health and Biosafety, Kunming University of Science and Technology, No.727 Jingming Road, Chenggong Campus, Kunming, Yunnan, China.
Papers in Europe PMC - 10Jiang S5 papers · 2026
Guangdong Provincial Center for Disease Control and Prevention, Guangzhou City, Guangdong Province, China.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
62
interventional trials for this specific condition
62 interventional trials matched this specific condition name; 12 currently recruiting in our sample.
Data as of 27 July 2026
62 interventional trials — more than 73% of diseases in the trials denominator have none at all (5114 of 7003; this disease is at the 97.5th percentile).
low confidence · 97.5th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
62 interventional trials matched after quoted-phrase search and title/condition post-filter.
- NCT06983548·NOT YET RECRUITING·Chikungunya Virus Detection in Semen
Conditions: Chikungunya Virus Infection·Matched via name phrase
- NCT07394426·NOT YET RECRUITING·A Phase I Study of PepGNP-ChikV in Healthy Volunteers
Conditions: Chikungunya · Chikungunya Fever · Chikungunya Virus Infection · Chikungunya Virus Infections·Matched via name + MeSH
- NCT06859619·NOT YET RECRUITING·Serological Measurement of Montpellier Professionals' Contacts with Infectious Agents Responsible for Animal-borne Diseases
Conditions: Leishmaniasis · Leptospirosis · Brucellosis · Q Fever·Matched via name phrase
- NCT06928753·RECRUITING·Real-world Effectiveness, Safety and Immunogenicity of Chikungunya Vaccination in Populations at Risk of Severe or Complicated Forms: Prospective Study in La Réunion
Conditions: Chikungunya Virus Infection·Matched via name phrase
- NCT07467707·RECRUITING·An Efficacy, Safety, and Immunogenicity Study of CHIKV VLP Vaccine for the Prevention of Chikungunya Disease in Adolescents and Adults
Conditions: Chikungunya Virus·Matched via name phrase
- NCT07600879·NOT YET RECRUITING·Effects Of A Rehabilitation Protocol On Muscle Strength, Muscle Fatigue And Postural Control In Post-Dengue And Chikungunya Patients
Conditions: Dengue · Chikungunya·Matched via name phrase
- NCT07190560·RECRUITING·Against Chikungunya Virus and Neonatal Infection
Conditions: Chikungunya Virus Infection · Neonatal · Transfusion · Encephalopathy·Matched via name phrase
- NCT06973772·NOT YET RECRUITING·Trial to Evaluate the Immunogenicity and Safety of the Co-administration of Live Attenuated Dengue and Chikungunya Vaccines Compared to Separate Administration in Adults Aged 18 to 59 Years.
Conditions: Dengue · Chikungunya·Matched via name phrase
- NCT07555392·RECRUITING·A Seamless Phase II/III, Observer-blind, to Evaluate Immunogenicity and Safety of Chikungunya Virus Vaccine in Healthy Subjects 12-65Years of Age.
Conditions: Active Immunisation for Chikungunya Virus Infection·Matched via name phrase
- NCT07126171·NOT YET RECRUITING·A Clinical Study on the Efficacy and Safety of Reduning Injection in the Treatment of Chikungunya Fever
Conditions: Chikungunya Fever·Matched via name + MeSH
- NCT07678619·ENROLLING BY INVITATION·Smart Analysis and Decision-Making for Emerging Infectious Diseases
Conditions: Emerging Infectious Diseases · COVID-19 · Influenza · Mpox (Monkeypox)·Matched via name + MeSH
- NCT07003984·RECRUITING·A Safety and Immunogenicity Study of CHIKV VLP Vaccine in Children.
Conditions: Chikungunya Virus·Matched via name phrase
Observational and natural-history studies
27 observational studies match this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.
Recruiting or not-yet-recruiting
- NCT07520279·ENROLLING BY INVITATION·Xpert® Tropical Fever Test on GeneXpert® Edge X System
Conditions: Malaria Fever · Zika · Dengue Fever · Leptospirosis·Matched via name phrase
- NCT07358910·RECRUITING·Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
Conditions: Dengue · Chikungunya · Zika Virus Infection · Japanese Encephalitis·Matched via name phrase
- NCT07347002·ENROLLING BY INVITATION·Observational Study to Assess the Effectiveness of VLA1553 Vaccine in Preventing Chikungunya During a Pilot Vaccination Strategy in Brazil
Conditions: Chikungunya Virus Infection·Matched via name phrase
- NCT07112846·NOT YET RECRUITING·Prospective Clinical Registry for Evaluation of Exanthematous Infections and Coinfections
Conditions: Exanthema · Dengue Fever · Chikungunya · Measles·Matched via name phrase
- NCT07120724·RECRUITING·Real-World Study on Chinese Medicine for Treating Chikungunya Fever
Conditions: Chikungunya Fever·Matched via name + MeSH
- NCT07414524·ENROLLING BY INVITATION·VLA1553-403 Pregnancy Surveillance Study
Conditions: Chikungunya Virus Infection·Matched via name phrase
Where to find support
We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Chikungunya" OR "Chikungunya fever" OR "Chikungunya virus infectious disease"
MeSH descriptor terms unioned into the query: Chikungunya Fever
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Chikungunya" OR "Chikungunya fever" OR "Chikungunya virus infectious disease"
Interventional trials matched via: both, phrase (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).
Study-type breakdown: 62 interventional · 27 observational · 0 expanded access. Only interventional studies enter the trial headline.
Query health: ok — strategies attempted: phrase, mesh; with hits: phrase, mesh
Run this search on ClinicalTrials.gov
Synonyms dropped by stoplist: Chikungunya virus caused disease or disorder; Chikungunya virus disease or disorder
Confidence reasoning
- Preferred label is short or not clearly distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
- Publication count (39025) is extremely high with unknown/missing prevalence — treat as possible over-matching, not proven research intensity
Ingested 2026-07-27T13:39:08.424Z
